Executive Team

Under the leadership of Chief Executive Officer, Mr. Enrique Conterno FibroGen’s executive team includes accomplished leaders with deep and broad experience. Supported by a staff of approximately 600 employees worldwide, we are focused on delivering first-in-class medicines for the treatment of unmet medical needs.

Enrique Conterno

Chief Executive Officer

Kirk Christoffersen

Chief Business Officer

Christine L. Chung

Senior Vice President,
China Operations

Mark Eisner, M.D.,
M.P.H.

Chief Medical Officer

Juan Graham

Chief Financial Officer

John Hunter, Ph.D.

Chief Scientific Officer

Michael D. Lowenstein,
J.D.

Chief Legal Officer

Leanne C. Price, J.D.

Chief Intellectual
Property Officer

Tricia Stewart

Chief People Officer

Thane Wettig

Chief Commercial Officer